Transferrin Receptor‐Mediated Iron Uptake Promotes Colon Tumorigenesis
Advanced Science · 2023-04 · 10 (10)
DOI: 10.1002/advs.202207693 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 26.01.2023. Verfasst von Hyeoncheol Kim und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, University of New Mexico, Albuquerque, NM, 87131, USA. Hauptthemen laut MEDLINE: Tankyrases, Colonic Neoplasms. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH HHS, NIEHS NIH HHS.
Abstract (Originalsprache)
Transferrin receptor (TFRC) is the major mediator for iron entry into a cell. Under excessive iron conditions, TFRC is expected to be reduced to lower iron uptake and toxicity. However, the mechanism whereby TFRC expression is maintained at high levels in iron‐enriched cancer cells and the contribution of TFRC to cancer development are enigmatic. Here the work shows TFRC is induced by adenomatous polyposis coli (APC) gene loss‐driven β ‐catenin activation in colorectal cancer, whereas TFRC‐mediated intratumoral iron accumulation potentiates β ‐catenin signaling by directly enhancing the activity of tankyrase. Disruption of TFRC leads to a reduction of colonic iron levels and iron‐dependent tankyrase activity, which caused stabilization of axis inhibition protein 2 (AXIN2) and subsequent repression of the β ‐catenin/c‐Myc/E2F Transcription Factor 1/DNA polymerase delta1 (POLD1) axis. POLD1 knockdown, iron chelation, and TFRC disruption increase DNA replication stress, DNA damage response, apoptosis, and reduce colon tumor growth. Importantly, a combination of iron chelators and DNA damaging agents increases DNA damage response and reduces colon tumor cell growth. TFRC‐mediated iron import is at the center of a novel feed‐forward loop that facilitates colonic epithelial cell survival. This discovery may provide novel strategies for colorectal cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, University of New Mexico, Albuquerque, NM, 87131, USA.
- Department of Pathology, University of New Mexico, Albuquerque, NM, 87131, USA.
- Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, 48109, USA.
- Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI, 48109, USA.
- Department of Pathology, The University of Michigan Medical School, Ann Arbor, MI, 48109, USA.
- Center for clinical research and translational medicine, Yangpu hospital, Tongji University School of Medicine, Shanghai, 200090, China.
ORCID-Profile: Xiang Xue
Förderung
- NCI NIH HHS
- NIH HHS
- NIEHS NIH HHS
- NIDDK NIH HHS
- NIGMS NIH HHS
- National Institutes of Health
- American Cancer Society
- National Cancer Institute
Zitieren
APA
Kim, H., Villareal, L. B., Liu, Z., Haneef, M., Falcon, D. M., Martin, D. R., Lee, H. J., Dame, M. K., Attili, D., Chen, Y., Varani, J., Spence, J. R., Kovbasnjuk, O., Colacino, J. A., Lyssiotis, C. A., Lin, H. C., Shah, Y. M., & Xue, X. (2023). Transferrin Receptor‐Mediated Iron Uptake Promotes Colon Tumorigenesis. Advanced Science, 10(10). https://doi.org/10.1002/advs.202207693
Vancouver
Kim H, Villareal LB, Liu Z, Haneef M, Falcon DM, Martin DR, et al. Transferrin Receptor‐Mediated Iron Uptake Promotes Colon Tumorigenesis. Advanced Science. 2023;10(10). doi:10.1002/advs.202207693
BibTeX
@article{Kim2023,
author = {Kim, Hyeoncheol and Villareal, Luke B and Liu, Zhaoli and Haneef, Mohammad and Falcon, Daniel M and Martin, David R and Lee, Ho-Joon and Dame, Michael K and Attili, Durga and Chen, Ying and Varani, James and Spence, Jason R and Kovbasnjuk, Olga and Colacino, Justin A and Lyssiotis, Costas A and Lin, Henry C and Shah, Yatrik M and Xue, Xiang},
title = {Transferrin Receptor‐Mediated Iron Uptake Promotes Colon Tumorigenesis},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {10},
doi = {10.1002/advs.202207693}
}
EUVIMED